Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study.
To compare prospectively the impact on ovarian reserve of total laparoscopic hysterectomy (TLH) and laparoscopic supracervical hysterectomy (LSH) for treating uterine fibroids as measured by serum anti-Mullerian hormone (AMH) levels. In this prospective study, 83 patients (aged 38-47 years) with symptomatic uterine fibroids underwent either TLH (n = 40) or LSH (n = 43) with conservation of both ovaries. Of these, 33 patients from the TLH group and 34 patients from the LSH group completed follow-up (Canadian Task Force Classification II-2). Hospital. Eighty-three patients aged 38-47 years. Patients with symptomatic uterine fibroids underwent either TLH (n = 40) or LSH (n = 43). Changes in ovarian reserve were investigated by measuring serum levels of AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) before surgery and at 1 month and 4 months after surgery. In both the TLH and LSH groups, serum AMH levels were significantly decreased at 1 month and 4 months postsurgery compared with baseline levels (p < .001). The decrease in serum AMH levels was greater in the TLH group than in the LSH group at 1 month postsurgery, but the difference was not statistically significant. The decrease in serum AMH levels was significantly greater in the LSH group at 4 months postsurgery (p < .001). In both groups, no significant changes in serum FSH, LH, or E2 levels were seen at 1 month or 4 months (p > .05). Serum AMH levels were decreased significantly at 4 months after hysterectomy, with a greater decrease in the TLH group compared with the LSH group, indicating the prognostic importance of serum AMH level in reflecting ovarian reserve in patients undergoing hysterectomy.